-+ 0.00%
-+ 0.00%
-+ 0.00%

SeaStar Medical to present SAVE registry data on SCD-PED outcomes in pediatric sepsis-associated AKI at ASN Kidney Week 2026

PUBT·10/02/2026 13:43:15
Listen to the news
SeaStar Medical to present SAVE registry data on SCD-PED outcomes in pediatric sepsis-associated AKI at ASN Kidney Week 2026
  • SeaStar Medical flagged new post-approval registry results for its QUELIMMUNE pediatric device, scheduled for presentation at ASN Kidney Week 2026.
  • The late-breaking poster compares SAVE Registry outcomes with a historical cohort in pediatric sepsis-associated acute kidney injury requiring renal replacement therapy.
  • Data indicate improved patient outcomes versus historical experience, supporting the product’s real-world performance in an ultra-rare, high-mortality setting.
  • Presentation is set for Oct. 22, 2026 in Denver, a potential catalyst for broader clinical adoption and payer discussions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020943PRIMZONEFULLFEED9838701) on October 02, 2026, and is solely responsible for the information contained therein.